References

The structural specificity of anti-phospholipid antibodies in autoimmune disease

10.1016/0009-3084(86)90076-9 · 1986 · External reference

Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems

10.1016/s0021-9258(18)67567-2 · 1986 · External reference

Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies

10.4049/jimmunol.139.8.2598 · 1987 · External reference

Phospholipid in the hexagonal II phase is immunogenic: Evidence for immunorecognition of nonbilayer lipid phases in vivo

10.1073/pnas.87.11.4112 · 1990 · External reference

A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification

10.1055/s-0038-1649671 · 1993 · External reference

Antiphospholipid antibody production during Mediterranean spotted fever

10.3109/08916939508993359 · 1995 · External reference

Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin

10.1055/s-0037-1615392 · 1998 · External reference

Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidyl-ethanolamine reactivity with thrombosis in autoimmune disease

1998 · External reference

Detection of anti-phosphatidylethanolamine antibodies using flow cytometry

10.1002/(sici)1097-0320(19990501)36:1<46::aid-cyto6>3.0.co;2-3 · 1999 · External reference

Association of lupus anticoagulant with antibody against phosphatidylserine

10.1016/0090-1229(87)90173-5 · 1987 · External reference

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

10.1136/ard.46.1.1 · 1987 · External reference

Phospholipid binding proteins required for antiphospholipid antibody detection—an overview

10.1111/j.1600-0897.1997.tb00198.x · 1997 · External reference

Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus

1988 · External reference

Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis

10.1136/ard.48.2.166 · 1989 · External reference

Evaluation of the clinical and laboratory associations of antiphosphatidylethanolamine antibodies

10.1016/0049-3848(90)90141-x · 1990 · External reference

Antiphosphatidylethanolamine antibody as the sole antiphospholipid antibody in systemic lupus erythematosus with thrombosis

1992 · External reference

Childhood-onset systemic lupus erythematosus: Antiphospholipid antibodies in 37 patients and their first-degree relatives

10.1542/peds.92.6.849 · 1993 · External reference

Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies

1993 · External reference

The effect of sera with antiphospholipid antibodies on endothelial cell procoagulant activity is dependent upon the charge of the phospholipids against which they are directed

10.1016/0049-3848(94)90159-7 · 1994 · External reference

Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus

10.1177/096120339300200305 · 1993 · External reference

Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases

1996 · External reference

Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity

1996 · External reference

Prevalence and kininogen-dependence of antiphosphatidyl-ethanolamine antibodies

1995 · External reference

Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells

10.1055/s-0038-1656363 · 1992 · External reference

Incidence of antiphospholipid antibodies in patients with monoclonal gammopathy of undetermined significance

10.1093/ajcp/101.4.471 · 1994 · External reference

Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and B2 glycoprotein-I plasma levels

10.3109/08916939309014642 · 1993 · External reference

Microtitre plate and assay buffer alter detection of antiphosphatidylethanolamine antibodies in lupus anticoagulant positive plasma

10.1016/s0049-3848(98)00175-3 · 1999 · External reference

Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex

10.1182/blood.v86.8.3083.bloodjournal8683083 · 1995 · External reference

Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidyl-ethanolamine antibodies

10.1055/s-0038-1650583 · 1996 · External reference

Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor

10.4049/jimmunol.148.12.3885 · 1992 · External reference

Development of the hemostatic system in the neonate and young infant

10.1097/00043426-199021000-00019 · 1990 · External reference

Evolution of blood coagulation activators and inhibitors in healthy human fetus

10.1182/blood.v88.3.900.900 · 1996 · External reference

Some autoantibodies detected in the phosphatidylethanolamine ELISA recognize factor XI and/or prekallikrein

1998 · External reference

Advantage of using both anionic and zwitterionic phospholipid antigens for the detection of antiphospholipid antibodies

10.1093/ajcp/106.4.549 · 1996 · External reference

High prevalence of antiphospholipid antibodies in disseminated intravascular coagulation

10.1055/s-0038-1650403 · 1996 · External reference

Lysophosphatidylethanolamine is the antigen to which apparent antibody to phosphatidylethanolamine binds

10.1007/bf00918652 · 1990 · External reference

Influence of the phosphatidylethanolamine (PE) and bovine serum origins on anti-PE antibody detection by ELISA

10.1016/s0049-3848(97)00032-7 · 1997 · External reference

Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test

10.1001/archinte.1986.00360230069012 · 1986 · External reference

A sensitive assay for anti-phosphatidylethanolamine antibody in patients with recurrent fetal loss

1990 · External reference

Specific antiphospholipid antibodies as a predictive variable in patients with recurrent pregnancy loss

10.1111/j.1600-0897.1993.tb00570.x · 1993 · External reference

Recurrent abortion and moderate or strong antiphospholipid antibody production

10.1016/s0020-7292(98)00099-x · 1998 · External reference

Patterns of anti-phospholipid antibody specificities

1991 · External reference

Autoantibodies in women with primary recurrent spontaneous abortion of unknown etiology

10.1016/0165-0378(92)90003-m · 1992 · External reference

Autoantibodies to phospholipids and nuclear antigens in non-pregnant and pregnant Colombian women with recurrent spontaneous abortions

10.1016/0165-0378(94)00906-n · 1995 · External reference

Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies

10.1016/s0015-0282(16)58565-3 · 1996 · External reference

Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome

10.1016/s0029-7844(97)00065-3 · 1997 · External reference

Antibodies to B2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study

10.1016/s0015-0282(98)00312-4 · 1998 · External reference

Antiphospholipid antibodies associated with implantation failure after IVF/ET

10.1023/a:1022588903620 · 1997 · External reference

Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses

10.1016/s0015-0282(99)00119-3 · 1999 · External reference

Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss?

10.1177/096120339600500515 · 1996 · External reference

Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss

10.1055/s-0037-1614001 · 2000 · External reference

Antiphospholipid antibodies are a risk factor for early renal allograft failure

10.1097/00007890-199907270-00014 · 1999 · External reference

Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients

10.1097/00007890-199901150-00015 · 1999 · External reference

Antiphospholipid antibodies in heart transplant recipients

10.1002/clc.4960181009 · 1995 · External reference

The evolution, evaluation and interpretation of antiphospholipid antibody assays

10.1016/0197-1859(95)80013-1 · 1995 · External reference

Antiphospholipid antibodies are implicated in early renal allograft failure

1998 · External reference

Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies

10.1111/j.1432-2277.2000.tb02122.x · 2000 · External reference

The pre-conditioning incidence of antiphospholipid antibodies is not significantly increased in patients with bone marrow transplant-related organ dysfunction

10.1038/sj.bmt.1701411 · 1998 · External reference

Antiphospholipid antibodies are a risk factor for early renal allograft failure: isolation of antiphospholipid antibodies from a thrombosed renal allograft

10.1016/s0041-1345(98)01629-7 · 1999 · External reference

Autoantibodies to kininogen-phosphatidylethanolamine complexes augment thrombin-induced platelet aggregation

10.1016/0049-3848(96)00165-x · 1996 · External reference

Antiphospholipid antibodies in left-ventricular assist system recipients after exposure to topical bovine thrombin

10.1016/s0041-1345(98)01479-1 · 1998 · External reference

Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients

10.1016/s0003-4975(99)00458-0 · 1999 · External reference

Antiphospholipid antibodies in sickle cell disease

10.1002/ajh.2830420409 · 1993 · External reference

Antiphospholipid antibodies in alcoholic liver disease

10.1002/hep.1840200614 · 1994 · External reference

Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: a unifying ‘membrane stress syndrome’ hypothesis

10.1177/096120339400300503 · 1994 · External reference

Antibodies against phospholipids and oxidized LDL in alcoholic patients

1998 · External reference

Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus

10.1046/j.1365-2249.1999.01014.x · 1999 · External reference

Henoch-Schonlein Purpura and stroke: antiphosphatidylethanolamine antibody (aPE) in CSF and serum

10.1212/wnl.55.9.1379 · 2000 · External reference

International consensus statement on preliminary classification criteria for define antiphospholipid syndrome: report of an international workshop

10.1002/1529-0131(199907)42:7<1309::aid-anr1>3.0.co;2-f · 1999 · External reference

Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome

10.1093/rheumatology/37.11.1229 · 1998 · External reference